Our Reports
Automotive Reports Electronics & Semiconductor Telecom & IT Technology & IT Consumer Goods Healthcare Food & Beverages Chemical
Our Links
About Us Contact Us Press Release News Our Blogs

Int'l : +1(646) 600-5072 | query@kbvresearch.com

Global PEGylated Proteins Market Size, Share & Industry Trends Analysis Report By Product & Services, By Type (Colony-stimulating Factor, Interferons, Recombinant Factor VII, Erythropoietin), By End-user, By Application, By Regional Outlook and Forecast, 2022 - 2028

Published Date : 30-Nov-2022

Pages: 278

Formats: PDF

COVID-19 Impact on the PEGylated Proteins Market

The Global PEGylated Proteins Market size is expected to reach $2.1 billion by 2028, rising at a market growth of 11.3% CAGR during the forecast period.

PEGylation is covalently and non-covalently connecting polyethylene glycol polymer chains to molecules, such as treatments, medications, or vesicles. The industry is expected to expand significantly throughout the anticipated time period, mainly due to increased PEGylation demand, a rise in the occurrence of chronic diseases, and the availability of effective new therapeutic options.

PEGylated Proteins Market - Global Opportunities and Trends Analysis Report 2018-2028

PEGylated chemicals also have certain extra advantages that support the growth of the sector, such as improved proteolytic defense, a longer half-life, decreased toxicity, and reduced immunogenicity. Because of their great biological activity and excellent selectivity, protein medicines have emerged as significant modern pharmacological products.

In combination with protein inactive necessary groups, polyethylene glycol (PEG), a type of non-toxic, high hydrophilic macromolecule polymer, increases the relative molecular mass of the protein drugs, causing some changes to the antigenic determinant that is covered on the surface of the charged property. Both domestically and internationally, there has been noticeable interest in the utilization of PEGylated technology in protein medicines.

A wide range of PEGylated medications on the market has completely established both their therapeutic and commercial usefulness. The preference for protein-based pharmaceuticals over non-protein-based drugs is increasing, and PEGylation's enhancement of protein stability and circulation half-life is anticipated to drive the PEGylated Protein Industry's expansion throughout the projection period.

The key driver of the industry's growth is the increasing prevalence of chronic conditions like cancer, kidney illness, and rheumatoid arthritis. For instance, according to estimations from the IARC (International Agency for Research on Cancer), there will be 19.3 million new cases of cancer and 10.3 million cancer deaths globally in 2020.

COVID-19 Impact Analysis

The COVID-19 pandemic was beneficial to the sector. The government and major players increased their investments in the creation of cutting-edge medication candidates for COVID-19 prevention. Increased research and development for new vaccines, diagnostics, and the repurposing of current medicines were closely linked to an increase in investments. For instance, Zydus Cadila, an Indian pharmaceutical company, acquired an Emergency Use Approval (EUA) in April 2021 to use its PEGylated Interferon alpha 2b existing medication to treat COVID-19 patients with mild instances. The medicine had previously been approved to treat Hepatitis B, but after extensive study and clinical trials across India, it was repurposed for COVID-19.

Market Growth Factors

Pegylated proteins are being used more often and in a variety of applications.

The development of more stable and non-immunogenic medicines is made possible by major improvements in PEGylated protein processes, which are predicted to accelerate the growth of the worldwide PEGylated protein market. Given the huge increase in cancer patients, the approach has strong applicability in the treatment of cancer. World Health Organization (WHO) estimates that 9.6 million individuals worldwide lost their lives to cancer in 2018. After being PEGylated, the protein from the CCN family can be employed in the treatment of blood cancer.

The Rising Rate Of Cancer Worldwide

The second-leading cause of death, cancer, is responsible for a significant fraction of all fatalities. Wealthy countries have a substantially higher cancer rate than developing ones. It is anticipated that recognized risk factors will be increasingly prominent in these developing nations due to population growth, aging, and a rise in known risk factors. Lung cancer is among the major cause of cancer-related death in men only in industrialized countries, while breast cancer is the major cause of cancer deaths in developing countries.

Market Restraining Factors

Isolation And Purification Challenges

Protein PEGylation is a complicated process that can be carried out in different ways, depending on the protein's makeup and the intended use. Inert PEG strings are covalently or non-covalently complexed with proteins of interest. Another crucial step is the purification of the PEGylated protein, which is mostly accomplished through chromatography and electrostatic interactions or molecular sizes. For conditions such as anemia, kidney illness, multiple sclerosis, hemophilia, and malignancies, a number of PEGylated medications are in use.

PEGylated Proteins Market Share and Industry Analysis Report 2021

Product and Services Outlook

Based on the Product and Services, the market is divided into Consumables and Services. The market's substantial revenue share is displayed by the services sector. PEGylated Proteins services are available in both linear and branching formats and can be used with PEGs of various molecular weights. Peptides and proteins frequently have limitations on their capacity to be used therapeutically due to their chemical instability, quick blood circulation, and propensity to trigger an immune response.

Type Outlook

Based on the type, the market is divided into Colony-stimulating factors, Interferons, Erythropoietin, Recombinant factor VII, and Others. Erythropoietin is demonstrating the market's optimistic growth pace. The expansion of erythropoietin drugs is being driven by an increase in the prevalence of chronic diseases such as end-stage renal diseases, cancer, HIV, and neurological disorders. Drugs that mimic erythropoietin (EPO) can be used to treat severe anemia in people with cancer, HIV, and renal disease.

Application Outlook

Based on Application, the market is divided into Cancer, Autoimmune diseases, Hepatitis, Multiple sclerosis, Hemophilia, Gastrointestinal disorders, and Others. The market is showing a promising growth rate for the other segments. Protein drug delivery and other disorders are included in the others section. The market for PEGylated Proteins is anticipated to grow as a result of the rising frequency of chronic disorders. PEGylated proteins improve a drug's action relative to a standard drug by increasing the stability of the substance in the body.

End-User Outlook

Based on the end-user, the market is divided into Pharmaceutical and biotechnology businesses, Contract research organizations, and Academic & research institutes. The significant revenue share in the industry was accounted for by Contract Research Organizations (CROs). CROs are currently more prevalent as a result of the rising demand for outside help with contract research and the creation of pharmaceuticals. Additionally, due to the hassle-free process and FDA clearance, the biotechnology and pharmaceutical industries now rely on CROs for support.

PEGylated Proteins Market Report Coverage
Report Attribute Details
Market size value in 2021 USD 1 Billion
Market size forecast in 2028 USD 2.1 Billion
Base Year 2021
Historical Period 2018 to 2020
Forecast Period 2022 to 2028
Revenue Growth Rate CAGR of 11.3% from 2022 to 2028
Number of Pages 278
Number of Tables 490
Report coverage Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Companies Strategic Developments, Company Profiling
Segments covered Product & Services, Type, End-user, Application, Region
Country scope US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria
Growth Drivers
  • Pegylated proteins are being used more often and in a variety of applications.
  • The Rising Rate Of Cancer Worldwide
Restraints
  • Isolation And Purification Challenges

Regional Outlook

Based on geography, the market is categorized into North America, Europe, Asia Pacific, and LAMEA. In 2021, North America led the market and held the largest share. The region's healthcare infrastructure has grown as a result of the incidence of ailments and diseases, chronic conditions, and population awareness of modern therapies. The increase in funding and grants for biologics-based research activities is facilitated by the presence of improved infrastructure and better economic conditions.

Free Valuable Insights: Global PEGylated Proteins Market size to reach USD 2.1 Billion by 2028

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Merck Millipore (Merck KGaA), Thermo Fisher Scientific, Inc., NOF Corporation, JenKem Technology Co. Ltd., Creative PEGworks, Celares GmbH, Quanta BioDesign, Ltd., Biomatrik, Inc., Iris Biotech GmbH, and Laysan Bio, Inc.

Strategies deployed in Unmanned PEGylated Proteins Market

  • Nov-2022: Thermo Fisher Scientific completed the acquisition of The Binding Site Group, a UK-based specialist protein company providing diagnostic products and instruments to clinicians and laboratories globally. This acquisition broadened Thermo's existing specialty diagnostics portfolio.
  • Aug-2022: Merck Group, the parent organization of Merck Millipore took over the Chemical division of Mecaro, a company focused on manufacturing heater blocks and chemical precursors for semiconductors. This acquisition enhances Merck's portfolio of semiconductor solutions.
  • Apr-2022: Thermo Fisher Scientific launched GMP-manufactured Gibco CTS TrueCut Cas9 protein. The product enhances Thermo's existing genome editing solutions and provides support to scientists developing personalized CAR T-cell therapeutics.
  • Mar-2022: Thermo Fisher took over Max Analytical, a chemical instrumentation company providing FTIR-based gas analytical solutions. The acquisition broadened Thermo's FTIR instrument, software, and service offerings.
  • Jan-2022: Thermo Fisher Scientific announced the acquisition of PeproTech, a provider of bioscience reagents. The acquisition complemented Thermo's bioscience business and enabled them to deliver better services to its pharma and biotech customers.
  • Dec-2021: Thermo Fisher acquired PPD, a pharmaceutical firm offering clinical research and laboratory services. The addition of PPD's clinical research services enables Thermo to advance its work in launching life-changing therapies to market.
  • Oct-2021: Thermo Fisher Scientific collaborated with 3M Health Car for maximizing process scalability and efficiency in commercial therapeutic manufacturing. The collaboration integrates Thermo's HyPerforma Single-Use Bioreactor Systems and 3M's Harvest RC providing premium solutions to advance manufacturing capacity to produce therapeutics.
  • Jan-2021: Thermo Fisher completed the acquisition of Mesa Biotech, a healthcare test and data company providing the molecular diagnostic test. This acquisition complemented Thermo's existing test services and helped Thermo cater to the increasing demand for COVID-related testing.

Scope of the Study

Market Segments Covered in the Report:

By Product & Services

  • Consumables
  • Services

By Type

  • Colony-stimulating Factor
  • Interferons
  • Recombinant Factor VII
  • Erythropoietin
  • Others

By End-user

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Academic & Research Institutes

By Application

  • Cancer
  • Autoimmune Diseases
  • Hepatitis
  • Multiple Sclerosis
  • Hemophilia
  • Gastrointestinal Disorders
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • Merck Millipore (Merck KGaA)
  • Thermo Fisher Scientific, Inc.
  • NOF Corporation
  • JenKem Technology Co. Ltd.
  • Creative PEGworks
  • Celares GmbH
  • Quanta BioDesign, Ltd.
  • Biomatrik, Inc.
  • Iris Biotech GmbH
  • Laysan Bio, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global PEGylated Proteins Market, by Product & Services
1.4.2 Global PEGylated Proteins Market, by Type
1.4.3 Global PEGylated Proteins Market, by End-user
1.4.4 Global PEGylated Proteins Market, by Application
1.4.5 Global PEGylated Proteins Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in PEGylated Proteins Market

Chapter 4. Global PEGylated Proteins Market by Product & Services
4.1 Global Consumables Market by Region
4.2 Global Services Market by Region

Chapter 5. Global PEGylated Proteins Market by Type
5.1 Global Colony-stimulating Factor Market by Region
5.2 Global Interferons Market by Region
5.3 Global Recombinant Factor VII Market by Region
5.4 Global Erythropoietin Market by Region
5.5 Global Others Market by Region

Chapter 6. Global PEGylated Proteins Market by End-user
6.1 Global Pharmaceutical & Biotechnology Companies Market by Region
6.2 Global Contract Research Organizations (CROs) Market by Region
6.3 Global Academic & Research Institutes Market by Region

Chapter 7. Global PEGylated Proteins Market by Application
7.1 Global Cancer Market by Region
7.2 Global Autoimmune Diseases Market by Region
7.3 Global Hepatitis Market by Region
7.4 Global Multiple Sclerosis Market by Region
7.5 Global Hemophilia Market by Region
7.6 Global Gastrointestinal Disorders Market by Region
7.7 Global Others Market by Region

Chapter 8. Global PEGylated Proteins Market by Region
8.1 North America PEGylated Proteins Market
8.1.1 North America PEGylated Proteins Market by Product & Services
8.1.1.1 North America Consumables Market by Country
8.1.1.2 North America Services Market by Country
8.1.2 North America PEGylated Proteins Market by Type
8.1.2.1 North America Colony-stimulating Factor Market by Country
8.1.2.2 North America Interferons Market by Country
8.1.2.3 North America Recombinant Factor VII Market by Country
8.1.2.4 North America Erythropoietin Market by Country
8.1.2.5 North America Others Market by Country
8.1.3 North America PEGylated Proteins Market by End-user
8.1.3.1 North America Pharmaceutical & Biotechnology Companies Market by Country
8.1.3.2 North America Contract Research Organizations (CROs) Market by Country
8.1.3.3 North America Academic & Research Institutes Market by Country
8.1.4 North America PEGylated Proteins Market by Application
8.1.4.1 North America Cancer Market by Country
8.1.4.2 North America Autoimmune Diseases Market by Country
8.1.4.3 North America Hepatitis Market by Country
8.1.4.4 North America Multiple Sclerosis Market by Country
8.1.4.5 North America Hemophilia Market by Country
8.1.4.6 North America Gastrointestinal Disorders Market by Country
8.1.4.7 North America Others Market by Country
8.1.5 North America PEGylated Proteins Market by Country
8.1.5.1 US PEGylated Proteins Market
8.1.5.1.1 US PEGylated Proteins Market by Product & Services
8.1.5.1.2 US PEGylated Proteins Market by Type
8.1.5.1.3 US PEGylated Proteins Market by End-user
8.1.5.1.4 US PEGylated Proteins Market by Application
8.1.5.2 Canada PEGylated Proteins Market
8.1.5.2.1 Canada PEGylated Proteins Market by Product & Services
8.1.5.2.2 Canada PEGylated Proteins Market by Type
8.1.5.2.3 Canada PEGylated Proteins Market by End-user
8.1.5.2.4 Canada PEGylated Proteins Market by Application
8.1.5.3 Mexico PEGylated Proteins Market
8.1.5.3.1 Mexico PEGylated Proteins Market by Product & Services
8.1.5.3.2 Mexico PEGylated Proteins Market by Type
8.1.5.3.3 Mexico PEGylated Proteins Market by End-user
8.1.5.3.4 Mexico PEGylated Proteins Market by Application
8.1.5.4 Rest of North America PEGylated Proteins Market
8.1.5.4.1 Rest of North America PEGylated Proteins Market by Product & Services
8.1.5.4.2 Rest of North America PEGylated Proteins Market by Type
8.1.5.4.3 Rest of North America PEGylated Proteins Market by End-user
8.1.5.4.4 Rest of North America PEGylated Proteins Market by Application
8.2 Europe PEGylated Proteins Market
8.2.1 Europe PEGylated Proteins Market by Product & Services
8.2.1.1 Europe Consumables Market by Country
8.2.1.2 Europe Services Market by Country
8.2.2 Europe PEGylated Proteins Market by Type
8.2.2.1 Europe Colony-stimulating Factor Market by Country
8.2.2.2 Europe Interferons Market by Country
8.2.2.3 Europe Recombinant Factor VII Market by Country
8.2.2.4 Europe Erythropoietin Market by Country
8.2.2.5 Europe Others Market by Country
8.2.3 Europe PEGylated Proteins Market by End-user
8.2.3.1 Europe Pharmaceutical & Biotechnology Companies Market by Country
8.2.3.2 Europe Contract Research Organizations (CROs) Market by Country
8.2.3.3 Europe Academic & Research Institutes Market by Country
8.2.4 Europe PEGylated Proteins Market by Application
8.2.4.1 Europe Cancer Market by Country
8.2.4.2 Europe Autoimmune Diseases Market by Country
8.2.4.3 Europe Hepatitis Market by Country
8.2.4.4 Europe Multiple Sclerosis Market by Country
8.2.4.5 Europe Hemophilia Market by Country
8.2.4.6 Europe Gastrointestinal Disorders Market by Country
8.2.4.7 Europe Others Market by Country
8.2.5 Europe PEGylated Proteins Market by Country
8.2.5.1 Germany PEGylated Proteins Market
8.2.5.1.1 Germany PEGylated Proteins Market by Product & Services
8.2.5.1.2 Germany PEGylated Proteins Market by Type
8.2.5.1.3 Germany PEGylated Proteins Market by End-user
8.2.5.1.4 Germany PEGylated Proteins Market by Application
8.2.5.2 UK PEGylated Proteins Market
8.2.5.2.1 UK PEGylated Proteins Market by Product & Services
8.2.5.2.2 UK PEGylated Proteins Market by Type
8.2.5.2.3 UK PEGylated Proteins Market by End-user
8.2.5.2.4 UK PEGylated Proteins Market by Application
8.2.5.3 France PEGylated Proteins Market
8.2.5.3.1 France PEGylated Proteins Market by Product & Services
8.2.5.3.2 France PEGylated Proteins Market by Type
8.2.5.3.3 France PEGylated Proteins Market by End-user
8.2.5.3.4 France PEGylated Proteins Market by Application
8.2.5.4 Russia PEGylated Proteins Market
8.2.5.4.1 Russia PEGylated Proteins Market by Product & Services
8.2.5.4.2 Russia PEGylated Proteins Market by Type
8.2.5.4.3 Russia PEGylated Proteins Market by End-user
8.2.5.4.4 Russia PEGylated Proteins Market by Application
8.2.5.5 Spain PEGylated Proteins Market
8.2.5.5.1 Spain PEGylated Proteins Market by Product & Services
8.2.5.5.2 Spain PEGylated Proteins Market by Type
8.2.5.5.3 Spain PEGylated Proteins Market by End-user
8.2.5.5.4 Spain PEGylated Proteins Market by Application
8.2.5.6 Italy PEGylated Proteins Market
8.2.5.6.1 Italy PEGylated Proteins Market by Product & Services
8.2.5.6.2 Italy PEGylated Proteins Market by Type
8.2.5.6.3 Italy PEGylated Proteins Market by End-user
8.2.5.6.4 Italy PEGylated Proteins Market by Application
8.2.5.7 Rest of Europe PEGylated Proteins Market
8.2.5.7.1 Rest of Europe PEGylated Proteins Market by Product & Services
8.2.5.7.2 Rest of Europe PEGylated Proteins Market by Type
8.2.5.7.3 Rest of Europe PEGylated Proteins Market by End-user
8.2.5.7.4 Rest of Europe PEGylated Proteins Market by Application
8.3 Asia Pacific PEGylated Proteins Market
8.3.1 Asia Pacific PEGylated Proteins Market by Product & Services
8.3.1.1 Asia Pacific Consumables Market by Country
8.3.1.2 Asia Pacific Services Market by Country
8.3.2 Asia Pacific PEGylated Proteins Market by Type
8.3.2.1 Asia Pacific Colony-stimulating Factor Market by Country
8.3.2.2 Asia Pacific Interferons Market by Country
8.3.2.3 Asia Pacific Recombinant Factor VII Market by Country
8.3.2.4 Asia Pacific Erythropoietin Market by Country
8.3.2.5 Asia Pacific Others Market by Country
8.3.3 Asia Pacific PEGylated Proteins Market by End-user
8.3.3.1 Asia Pacific Pharmaceutical & Biotechnology Companies Market by Country
8.3.3.2 Asia Pacific Contract Research Organizations (CROs) Market by Country
8.3.3.3 Asia Pacific Academic & Research Institutes Market by Country
8.3.4 Asia Pacific PEGylated Proteins Market by Application
8.3.4.1 Asia Pacific Cancer Market by Country
8.3.4.2 Asia Pacific Autoimmune Diseases Market by Country
8.3.4.3 Asia Pacific Hepatitis Market by Country
8.3.4.4 Asia Pacific Multiple Sclerosis Market by Country
8.3.4.5 Asia Pacific Hemophilia Market by Country
8.3.4.6 Asia Pacific Gastrointestinal Disorders Market by Country
8.3.4.7 Asia Pacific Others Market by Country
8.3.5 Asia Pacific PEGylated Proteins Market by Country
8.3.5.1 China PEGylated Proteins Market
8.3.5.1.1 China PEGylated Proteins Market by Product & Services
8.3.5.1.2 China PEGylated Proteins Market by Type
8.3.5.1.3 China PEGylated Proteins Market by End-user
8.3.5.1.4 China PEGylated Proteins Market by Application
8.3.5.2 Japan PEGylated Proteins Market
8.3.5.2.1 Japan PEGylated Proteins Market by Product & Services
8.3.5.2.2 Japan PEGylated Proteins Market by Type
8.3.5.2.3 Japan PEGylated Proteins Market by End-user
8.3.5.2.4 Japan PEGylated Proteins Market by Application
8.3.5.3 India PEGylated Proteins Market
8.3.5.3.1 India PEGylated Proteins Market by Product & Services
8.3.5.3.2 India PEGylated Proteins Market by Type
8.3.5.3.3 India PEGylated Proteins Market by End-user
8.3.5.3.4 India PEGylated Proteins Market by Application
8.3.5.4 South Korea PEGylated Proteins Market
8.3.5.4.1 South Korea PEGylated Proteins Market by Product & Services
8.3.5.4.2 South Korea PEGylated Proteins Market by Type
8.3.5.4.3 South Korea PEGylated Proteins Market by End-user
8.3.5.4.4 South Korea PEGylated Proteins Market by Application
8.3.5.5 Singapore PEGylated Proteins Market
8.3.5.5.1 Singapore PEGylated Proteins Market by Product & Services
8.3.5.5.2 Singapore PEGylated Proteins Market by Type
8.3.5.5.3 Singapore PEGylated Proteins Market by End-user
8.3.5.5.4 Singapore PEGylated Proteins Market by Application
8.3.5.6 Malaysia PEGylated Proteins Market
8.3.5.6.1 Malaysia PEGylated Proteins Market by Product & Services
8.3.5.6.2 Malaysia PEGylated Proteins Market by Type
8.3.5.6.3 Malaysia PEGylated Proteins Market by End-user
8.3.5.6.4 Malaysia PEGylated Proteins Market by Application
8.3.5.7 Rest of Asia Pacific PEGylated Proteins Market
8.3.5.7.1 Rest of Asia Pacific PEGylated Proteins Market by Product & Services
8.3.5.7.2 Rest of Asia Pacific PEGylated Proteins Market by Type
8.3.5.7.3 Rest of Asia Pacific PEGylated Proteins Market by End-user
8.3.5.7.4 Rest of Asia Pacific PEGylated Proteins Market by Application
8.4 LAMEA PEGylated Proteins Market
8.4.1 LAMEA PEGylated Proteins Market by Product & Services
8.4.1.1 LAMEA Consumables Market by Country
8.4.1.2 LAMEA Services Market by Country
8.4.2 LAMEA PEGylated Proteins Market by Type
8.4.2.1 LAMEA Colony-stimulating Factor Market by Country
8.4.2.2 LAMEA Interferons Market by Country
8.4.2.3 LAMEA Recombinant Factor VII Market by Country
8.4.2.4 LAMEA Erythropoietin Market by Country
8.4.2.5 LAMEA Others Market by Country
8.4.3 LAMEA PEGylated Proteins Market by End-user
8.4.3.1 LAMEA Pharmaceutical & Biotechnology Companies Market by Country
8.4.3.2 LAMEA Contract Research Organizations (CROs) Market by Country
8.4.3.3 LAMEA Academic & Research Institutes Market by Country
8.4.4 LAMEA PEGylated Proteins Market by Application
8.4.4.1 LAMEA Cancer Market by Country
8.4.4.2 LAMEA Autoimmune Diseases Market by Country
8.4.4.3 LAMEA Hepatitis Market by Country
8.4.4.4 LAMEA Multiple Sclerosis Market by Country
8.4.4.5 LAMEA Hemophilia Market by Country
8.4.4.6 LAMEA Gastrointestinal Disorders Market by Country
8.4.4.7 LAMEA Others Market by Country
8.4.5 LAMEA PEGylated Proteins Market by Country
8.4.5.1 Brazil PEGylated Proteins Market
8.4.5.1.1 Brazil PEGylated Proteins Market by Product & Services
8.4.5.1.2 Brazil PEGylated Proteins Market by Type
8.4.5.1.3 Brazil PEGylated Proteins Market by End-user
8.4.5.1.4 Brazil PEGylated Proteins Market by Application
8.4.5.2 Argentina PEGylated Proteins Market
8.4.5.2.1 Argentina PEGylated Proteins Market by Product & Services
8.4.5.2.2 Argentina PEGylated Proteins Market by Type
8.4.5.2.3 Argentina PEGylated Proteins Market by End-user
8.4.5.2.4 Argentina PEGylated Proteins Market by Application
8.4.5.3 UAE PEGylated Proteins Market
8.4.5.3.1 UAE PEGylated Proteins Market by Product & Services
8.4.5.3.2 UAE PEGylated Proteins Market by Type
8.4.5.3.3 UAE PEGylated Proteins Market by End-user
8.4.5.3.4 UAE PEGylated Proteins Market by Application
8.4.5.4 Saudi Arabia PEGylated Proteins Market
8.4.5.4.1 Saudi Arabia PEGylated Proteins Market by Product & Services
8.4.5.4.2 Saudi Arabia PEGylated Proteins Market by Type
8.4.5.4.3 Saudi Arabia PEGylated Proteins Market by End-user
8.4.5.4.4 Saudi Arabia PEGylated Proteins Market by Application
8.4.5.5 South Africa PEGylated Proteins Market
8.4.5.5.1 South Africa PEGylated Proteins Market by Product & Services
8.4.5.5.2 South Africa PEGylated Proteins Market by Type
8.4.5.5.3 South Africa PEGylated Proteins Market by End-user
8.4.5.5.4 South Africa PEGylated Proteins Market by Application
8.4.5.6 Nigeria PEGylated Proteins Market
8.4.5.6.1 Nigeria PEGylated Proteins Market by Product & Services
8.4.5.6.2 Nigeria PEGylated Proteins Market by Type
8.4.5.6.3 Nigeria PEGylated Proteins Market by End-user
8.4.5.6.4 Nigeria PEGylated Proteins Market by Application
8.4.5.7 Rest of LAMEA PEGylated Proteins Market
8.4.5.7.1 Rest of LAMEA PEGylated Proteins Market by Product & Services
8.4.5.7.2 Rest of LAMEA PEGylated Proteins Market by Type
8.4.5.7.3 Rest of LAMEA PEGylated Proteins Market by End-user
8.4.5.7.4 Rest of LAMEA PEGylated Proteins Market by Application

Chapter 9. Company Profiles
9.1 Thermo Fisher Scientific, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.5.2 Product Launches and Product Expansions:
9.1.5.3 Acquisition and Mergers:
9.2 Merck Millipore ( Merck Group)
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Partnerships, Collaborations, and Agreements:
9.3 NOF Corporation
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expenses
9.4 Beijing Jiankai Technology Co., Ltd. (Jenkem)
9.4.1 Company Overview
9.5 Creative PEGworks
9.5.1 Company Overview
9.6 Celares GmbH
9.6.1 Company Overview
9.7 Quanta BioDesign Ltd.
9.7.1 Company Overview
9.8 Biomatrik, Inc.
9.8.1 Company Overview
9.9 Iris Biotech GmbH
9.9.1 Company Overview
9.10. Laysan Bio, Inc.
9.10.1 Company Overview
TABLE 1 Global PEGylated Proteins Market, 2018 - 2021, USD Million
TABLE 2 Global PEGylated Proteins Market, 2022 - 2028, USD Million
TABLE 3 Global PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
TABLE 4 Global PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
TABLE 5 Global Consumables Market by Region, 2018 - 2021, USD Million
TABLE 6 Global Consumables Market by Region, 2022 - 2028, USD Million
TABLE 7 Global Services Market by Region, 2018 - 2021, USD Million
TABLE 8 Global Services Market by Region, 2022 - 2028, USD Million
TABLE 9 Global PEGylated Proteins Market by Type, 2018 - 2021, USD Million
TABLE 10 Global PEGylated Proteins Market by Type, 2022 - 2028, USD Million
TABLE 11 Global Colony-stimulating Factor Market by Region, 2018 - 2021, USD Million
TABLE 12 Global Colony-stimulating Factor Market by Region, 2022 - 2028, USD Million
TABLE 13 Global Interferons Market by Region, 2018 - 2021, USD Million
TABLE 14 Global Interferons Market by Region, 2022 - 2028, USD Million
TABLE 15 Global Recombinant Factor VII Market by Region, 2018 - 2021, USD Million
TABLE 16 Global Recombinant Factor VII Market by Region, 2022 - 2028, USD Million
TABLE 17 Global Erythropoietin Market by Region, 2018 - 2021, USD Million
TABLE 18 Global Erythropoietin Market by Region, 2022 - 2028, USD Million
TABLE 19 Global Others Market by Region, 2018 - 2021, USD Million
TABLE 20 Global Others Market by Region, 2022 - 2028, USD Million
TABLE 21 Global PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
TABLE 22 Global PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
TABLE 23 Global Pharmaceutical & Biotechnology Companies Market by Region, 2018 - 2021, USD Million
TABLE 24 Global Pharmaceutical & Biotechnology Companies Market by Region, 2022 - 2028, USD Million
TABLE 25 Global Contract Research Organizations (CROs) Market by Region, 2018 - 2021, USD Million
TABLE 26 Global Contract Research Organizations (CROs) Market by Region, 2022 - 2028, USD Million
TABLE 27 Global Academic & Research Institutes Market by Region, 2018 - 2021, USD Million
TABLE 28 Global Academic & Research Institutes Market by Region, 2022 - 2028, USD Million
TABLE 29 Global PEGylated Proteins Market by Application, 2018 - 2021, USD Million
TABLE 30 Global PEGylated Proteins Market by Application, 2022 - 2028, USD Million
TABLE 31 Global Cancer Market by Region, 2018 - 2021, USD Million
TABLE 32 Global Cancer Market by Region, 2022 - 2028, USD Million
TABLE 33 Global Autoimmune Diseases Market by Region, 2018 - 2021, USD Million
TABLE 34 Global Autoimmune Diseases Market by Region, 2022 - 2028, USD Million
TABLE 35 Global Hepatitis Market by Region, 2018 - 2021, USD Million
TABLE 36 Global Hepatitis Market by Region, 2022 - 2028, USD Million
TABLE 37 Global Multiple Sclerosis Market by Region, 2018 - 2021, USD Million
TABLE 38 Global Multiple Sclerosis Market by Region, 2022 - 2028, USD Million
TABLE 39 Global Hemophilia Market by Region, 2018 - 2021, USD Million
TABLE 40 Global Hemophilia Market by Region, 2022 - 2028, USD Million
TABLE 41 Global Gastrointestinal Disorders Market by Region, 2018 - 2021, USD Million
TABLE 42 Global Gastrointestinal Disorders Market by Region, 2022 - 2028, USD Million
TABLE 43 Global Others Market by Region, 2018 - 2021, USD Million
TABLE 44 Global Others Market by Region, 2022 - 2028, USD Million
TABLE 45 Global PEGylated Proteins Market by Region, 2018 - 2021, USD Million
TABLE 46 Global PEGylated Proteins Market by Region, 2022 - 2028, USD Million
TABLE 47 North America PEGylated Proteins Market, 2018 - 2021, USD Million
TABLE 48 North America PEGylated Proteins Market, 2022 - 2028, USD Million
TABLE 49 North America PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
TABLE 50 North America PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
TABLE 51 North America Consumables Market by Country, 2018 - 2021, USD Million
TABLE 52 North America Consumables Market by Country, 2022 - 2028, USD Million
TABLE 53 North America Services Market by Country, 2018 - 2021, USD Million
TABLE 54 North America Services Market by Country, 2022 - 2028, USD Million
TABLE 55 North America PEGylated Proteins Market by Type, 2018 - 2021, USD Million
TABLE 56 North America PEGylated Proteins Market by Type, 2022 - 2028, USD Million
TABLE 57 North America Colony-stimulating Factor Market by Country, 2018 - 2021, USD Million
TABLE 58 North America Colony-stimulating Factor Market by Country, 2022 - 2028, USD Million
TABLE 59 North America Interferons Market by Country, 2018 - 2021, USD Million
TABLE 60 North America Interferons Market by Country, 2022 - 2028, USD Million
TABLE 61 North America Recombinant Factor VII Market by Country, 2018 - 2021, USD Million
TABLE 62 North America Recombinant Factor VII Market by Country, 2022 - 2028, USD Million
TABLE 63 North America Erythropoietin Market by Country, 2018 - 2021, USD Million
TABLE 64 North America Erythropoietin Market by Country, 2022 - 2028, USD Million
TABLE 65 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 66 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 67 North America PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
TABLE 68 North America PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
TABLE 69 North America Pharmaceutical & Biotechnology Companies Market by Country, 2018 - 2021, USD Million
TABLE 70 North America Pharmaceutical & Biotechnology Companies Market by Country, 2022 - 2028, USD Million
TABLE 71 North America Contract Research Organizations (CROs) Market by Country, 2018 - 2021, USD Million
TABLE 72 North America Contract Research Organizations (CROs) Market by Country, 2022 - 2028, USD Million
TABLE 73 North America Academic & Research Institutes Market by Country, 2018 - 2021, USD Million
TABLE 74 North America Academic & Research Institutes Market by Country, 2022 - 2028, USD Million
TABLE 75 North America PEGylated Proteins Market by Application, 2018 - 2021, USD Million
TABLE 76 North America PEGylated Proteins Market by Application, 2022 - 2028, USD Million
TABLE 77 North America Cancer Market by Country, 2018 - 2021, USD Million
TABLE 78 North America Cancer Market by Country, 2022 - 2028, USD Million
TABLE 79 North America Autoimmune Diseases Market by Country, 2018 - 2021, USD Million
TABLE 80 North America Autoimmune Diseases Market by Country, 2022 - 2028, USD Million
TABLE 81 North America Hepatitis Market by Country, 2018 - 2021, USD Million
TABLE 82 North America Hepatitis Market by Country, 2022 - 2028, USD Million
TABLE 83 North America Multiple Sclerosis Market by Country, 2018 - 2021, USD Million
TABLE 84 North America Multiple Sclerosis Market by Country, 2022 - 2028, USD Million
TABLE 85 North America Hemophilia Market by Country, 2018 - 2021, USD Million
TABLE 86 North America Hemophilia Market by Country, 2022 - 2028, USD Million
TABLE 87 North America Gastrointestinal Disorders Market by Country, 2018 - 2021, USD Million
TABLE 88 North America Gastrointestinal Disorders Market by Country, 2022 - 2028, USD Million
TABLE 89 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 90 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 91 North America PEGylated Proteins Market by Country, 2018 - 2021, USD Million
TABLE 92 North America PEGylated Proteins Market by Country, 2022 - 2028, USD Million
TABLE 93 US PEGylated Proteins Market, 2018 - 2021, USD Million
TABLE 94 US PEGylated Proteins Market, 2022 - 2028, USD Million
TABLE 95 US PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
TABLE 96 US PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
TABLE 97 US PEGylated Proteins Market by Type, 2018 - 2021, USD Million
TABLE 98 US PEGylated Proteins Market by Type, 2022 - 2028, USD Million
TABLE 99 US PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
TABLE 100 US PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
TABLE 101 US PEGylated Proteins Market by Application, 2018 - 2021, USD Million
TABLE 102 US PEGylated Proteins Market by Application, 2022 - 2028, USD Million
TABLE 103 Canada PEGylated Proteins Market, 2018 - 2021, USD Million
TABLE 104 Canada PEGylated Proteins Market, 2022 - 2028, USD Million
TABLE 105 Canada PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
TABLE 106 Canada PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
TABLE 107 Canada PEGylated Proteins Market by Type, 2018 - 2021, USD Million
TABLE 108 Canada PEGylated Proteins Market by Type, 2022 - 2028, USD Million
TABLE 109 Canada PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
TABLE 110 Canada PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
TABLE 111 Canada PEGylated Proteins Market by Application, 2018 - 2021, USD Million
TABLE 112 Canada PEGylated Proteins Market by Application, 2022 - 2028, USD Million
TABLE 113 Mexico PEGylated Proteins Market, 2018 - 2021, USD Million
TABLE 114 Mexico PEGylated Proteins Market, 2022 - 2028, USD Million
TABLE 115 Mexico PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
TABLE 116 Mexico PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
TABLE 117 Mexico PEGylated Proteins Market by Type, 2018 - 2021, USD Million
TABLE 118 Mexico PEGylated Proteins Market by Type, 2022 - 2028, USD Million
TABLE 119 Mexico PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
TABLE 120 Mexico PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
TABLE 121 Mexico PEGylated Proteins Market by Application, 2018 - 2021, USD Million
TABLE 122 Mexico PEGylated Proteins Market by Application, 2022 - 2028, USD Million
TABLE 123 Rest of North America PEGylated Proteins Market, 2018 - 2021, USD Million
TABLE 124 Rest of North America PEGylated Proteins Market, 2022 - 2028, USD Million
TABLE 125 Rest of North America PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
TABLE 126 Rest of North America PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
TABLE 127 Rest of North America PEGylated Proteins Market by Type, 2018 - 2021, USD Million
TABLE 128 Rest of North America PEGylated Proteins Market by Type, 2022 - 2028, USD Million
TABLE 129 Rest of North America PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
TABLE 130 Rest of North America PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
TABLE 131 Rest of North America PEGylated Proteins Market by Application, 2018 - 2021, USD Million
TABLE 132 Rest of North America PEGylated Proteins Market by Application, 2022 - 2028, USD Million
TABLE 133 Europe PEGylated Proteins Market, 2018 - 2021, USD Million
TABLE 134 Europe PEGylated Proteins Market, 2022 - 2028, USD Million
TABLE 135 Europe PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
TABLE 136 Europe PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
TABLE 137 Europe Consumables Market by Country, 2018 - 2021, USD Million
TABLE 138 Europe Consumables Market by Country, 2022 - 2028, USD Million
TABLE 139 Europe Services Market by Country, 2018 - 2021, USD Million
TABLE 140 Europe Services Market by Country, 2022 - 2028, USD Million
TABLE 141 Europe PEGylated Proteins Market by Type, 2018 - 2021, USD Million
TABLE 142 Europe PEGylated Proteins Market by Type, 2022 - 2028, USD Million
TABLE 143 Europe Colony-stimulating Factor Market by Country, 2018 - 2021, USD Million
TABLE 144 Europe Colony-stimulating Factor Market by Country, 2022 - 2028, USD Million
TABLE 145 Europe Interferons Market by Country, 2018 - 2021, USD Million
TABLE 146 Europe Interferons Market by Country, 2022 - 2028, USD Million
TABLE 147 Europe Recombinant Factor VII Market by Country, 2018 - 2021, USD Million
TABLE 148 Europe Recombinant Factor VII Market by Country, 2022 - 2028, USD Million
TABLE 149 Europe Erythropoietin Market by Country, 2018 - 2021, USD Million
TABLE 150 Europe Erythropoietin Market by Country, 2022 - 2028, USD Million
TABLE 151 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 152 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 153 Europe PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
TABLE 154 Europe PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
TABLE 155 Europe Pharmaceutical & Biotechnology Companies Market by Country, 2018 - 2021, USD Million
TABLE 156 Europe Pharmaceutical & Biotechnology Companies Market by Country, 2022 - 2028, USD Million
TABLE 157 Europe Contract Research Organizations (CROs) Market by Country, 2018 - 2021, USD Million
TABLE 158 Europe Contract Research Organizations (CROs) Market by Country, 2022 - 2028, USD Million
TABLE 159 Europe Academic & Research Institutes Market by Country, 2018 - 2021, USD Million
TABLE 160 Europe Academic & Research Institutes Market by Country, 2022 - 2028, USD Million
TABLE 161 Europe PEGylated Proteins Market by Application, 2018 - 2021, USD Million
TABLE 162 Europe PEGylated Proteins Market by Application, 2022 - 2028, USD Million
TABLE 163 Europe Cancer Market by Country, 2018 - 2021, USD Million
TABLE 164 Europe Cancer Market by Country, 2022 - 2028, USD Million
TABLE 165 Europe Autoimmune Diseases Market by Country, 2018 - 2021, USD Million
TABLE 166 Europe Autoimmune Diseases Market by Country, 2022 - 2028, USD Million
TABLE 167 Europe Hepatitis Market by Country, 2018 - 2021, USD Million
TABLE 168 Europe Hepatitis Market by Country, 2022 - 2028, USD Million
TABLE 169 Europe Multiple Sclerosis Market by Country, 2018 - 2021, USD Million
TABLE 170 Europe Multiple Sclerosis Market by Country, 2022 - 2028, USD Million
TABLE 171 Europe Hemophilia Market by Country, 2018 - 2021, USD Million
TABLE 172 Europe Hemophilia Market by Country, 2022 - 2028, USD Million
TABLE 173 Europe Gastrointestinal Disorders Market by Country, 2018 - 2021, USD Million
TABLE 174 Europe Gastrointestinal Disorders Market by Country, 2022 - 2028, USD Million
TABLE 175 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 176 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 177 Europe PEGylated Proteins Market by Country, 2018 - 2021, USD Million
TABLE 178 Europe PEGylated Proteins Market by Country, 2022 - 2028, USD Million
TABLE 179 Germany PEGylated Proteins Market, 2018 - 2021, USD Million
TABLE 180 Germany PEGylated Proteins Market, 2022 - 2028, USD Million
TABLE 181 Germany PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
TABLE 182 Germany PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
TABLE 183 Germany PEGylated Proteins Market by Type, 2018 - 2021, USD Million
TABLE 184 Germany PEGylated Proteins Market by Type, 2022 - 2028, USD Million
TABLE 185 Germany PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
TABLE 186 Germany PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
TABLE 187 Germany PEGylated Proteins Market by Application, 2018 - 2021, USD Million
TABLE 188 Germany PEGylated Proteins Market by Application, 2022 - 2028, USD Million
TABLE 189 UK PEGylated Proteins Market, 2018 - 2021, USD Million
TABLE 190 UK PEGylated Proteins Market, 2022 - 2028, USD Million
TABLE 191 UK PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
TABLE 192 UK PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
TABLE 193 UK PEGylated Proteins Market by Type, 2018 - 2021, USD Million
TABLE 194 UK PEGylated Proteins Market by Type, 2022 - 2028, USD Million
TABLE 195 UK PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
TABLE 196 UK PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
TABLE 197 UK PEGylated Proteins Market by Application, 2018 - 2021, USD Million
TABLE 198 UK PEGylated Proteins Market by Application, 2022 - 2028, USD Million
TABLE 199 France PEGylated Proteins Market, 2018 - 2021, USD Million
TABLE 200 France PEGylated Proteins Market, 2022 - 2028, USD Million
TABLE 201 France PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
TABLE 202 France PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
TABLE 203 France PEGylated Proteins Market by Type, 2018 - 2021, USD Million
TABLE 204 France PEGylated Proteins Market by Type, 2022 - 2028, USD Million
TABLE 205 France PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
TABLE 206 France PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
TABLE 207 France PEGylated Proteins Market by Application, 2018 - 2021, USD Million
TABLE 208 France PEGylated Proteins Market by Application, 2022 - 2028, USD Million
TABLE 209 Russia PEGylated Proteins Market, 2018 - 2021, USD Million
TABLE 210 Russia PEGylated Proteins Market, 2022 - 2028, USD Million
TABLE 211 Russia PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
TABLE 212 Russia PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
TABLE 213 Russia PEGylated Proteins Market by Type, 2018 - 2021, USD Million
TABLE 214 Russia PEGylated Proteins Market by Type, 2022 - 2028, USD Million
TABLE 215 Russia PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
TABLE 216 Russia PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
TABLE 217 Russia PEGylated Proteins Market by Application, 2018 - 2021, USD Million
TABLE 218 Russia PEGylated Proteins Market by Application, 2022 - 2028, USD Million
TABLE 219 Spain PEGylated Proteins Market, 2018 - 2021, USD Million
TABLE 220 Spain PEGylated Proteins Market, 2022 - 2028, USD Million
TABLE 221 Spain PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
TABLE 222 Spain PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
TABLE 223 Spain PEGylated Proteins Market by Type, 2018 - 2021, USD Million
TABLE 224 Spain PEGylated Proteins Market by Type, 2022 - 2028, USD Million
TABLE 225 Spain PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
TABLE 226 Spain PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
TABLE 227 Spain PEGylated Proteins Market by Application, 2018 - 2021, USD Million
TABLE 228 Spain PEGylated Proteins Market by Application, 2022 - 2028, USD Million
TABLE 229 Italy PEGylated Proteins Market, 2018 - 2021, USD Million
TABLE 230 Italy PEGylated Proteins Market, 2022 - 2028, USD Million
TABLE 231 Italy PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
TABLE 232 Italy PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
TABLE 233 Italy PEGylated Proteins Market by Type, 2018 - 2021, USD Million
TABLE 234 Italy PEGylated Proteins Market by Type, 2022 - 2028, USD Million
TABLE 235 Italy PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
TABLE 236 Italy PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
TABLE 237 Italy PEGylated Proteins Market by Application, 2018 - 2021, USD Million
TABLE 238 Italy PEGylated Proteins Market by Application, 2022 - 2028, USD Million
TABLE 239 Rest of Europe PEGylated Proteins Market, 2018 - 2021, USD Million
TABLE 240 Rest of Europe PEGylated Proteins Market, 2022 - 2028, USD Million
TABLE 241 Rest of Europe PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
TABLE 242 Rest of Europe PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
TABLE 243 Rest of Europe PEGylated Proteins Market by Type, 2018 - 2021, USD Million
TABLE 244 Rest of Europe PEGylated Proteins Market by Type, 2022 - 2028, USD Million
TABLE 245 Rest of Europe PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
TABLE 246 Rest of Europe PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
TABLE 247 Rest of Europe PEGylated Proteins Market by Application, 2018 - 2021, USD Million
TABLE 248 Rest of Europe PEGylated Proteins Market by Application, 2022 - 2028, USD Million
TABLE 249 Asia Pacific PEGylated Proteins Market, 2018 - 2021, USD Million
TABLE 250 Asia Pacific PEGylated Proteins Market, 2022 - 2028, USD Million
TABLE 251 Asia Pacific PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
TABLE 252 Asia Pacific PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
TABLE 253 Asia Pacific Consumables Market by Country, 2018 - 2021, USD Million
TABLE 254 Asia Pacific Consumables Market by Country, 2022 - 2028, USD Million
TABLE 255 Asia Pacific Services Market by Country, 2018 - 2021, USD Million
TABLE 256 Asia Pacific Services Market by Country, 2022 - 2028, USD Million
TABLE 257 Asia Pacific PEGylated Proteins Market by Type, 2018 - 2021, USD Million
TABLE 258 Asia Pacific PEGylated Proteins Market by Type, 2022 - 2028, USD Million
TABLE 259 Asia Pacific Colony-stimulating Factor Market by Country, 2018 - 2021, USD Million
TABLE 260 Asia Pacific Colony-stimulating Factor Market by Country, 2022 - 2028, USD Million
TABLE 261 Asia Pacific Interferons Market by Country, 2018 - 2021, USD Million
TABLE 262 Asia Pacific Interferons Market by Country, 2022 - 2028, USD Million
TABLE 263 Asia Pacific Recombinant Factor VII Market by Country, 2018 - 2021, USD Million
TABLE 264 Asia Pacific Recombinant Factor VII Market by Country, 2022 - 2028, USD Million
TABLE 265 Asia Pacific Erythropoietin Market by Country, 2018 - 2021, USD Million
TABLE 266 Asia Pacific Erythropoietin Market by Country, 2022 - 2028, USD Million
TABLE 267 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 268 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 269 Asia Pacific PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
TABLE 270 Asia Pacific PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
TABLE 271 Asia Pacific Pharmaceutical & Biotechnology Companies Market by Country, 2018 - 2021, USD Million
TABLE 272 Asia Pacific Pharmaceutical & Biotechnology Companies Market by Country, 2022 - 2028, USD Million
TABLE 273 Asia Pacific Contract Research Organizations (CROs) Market by Country, 2018 - 2021, USD Million
TABLE 274 Asia Pacific Contract Research Organizations (CROs) Market by Country, 2022 - 2028, USD Million
TABLE 275 Asia Pacific Academic & Research Institutes Market by Country, 2018 - 2021, USD Million
TABLE 276 Asia Pacific Academic & Research Institutes Market by Country, 2022 - 2028, USD Million
TABLE 277 Asia Pacific PEGylated Proteins Market by Application, 2018 - 2021, USD Million
TABLE 278 Asia Pacific PEGylated Proteins Market by Application, 2022 - 2028, USD Million
TABLE 279 Asia Pacific Cancer Market by Country, 2018 - 2021, USD Million
TABLE 280 Asia Pacific Cancer Market by Country, 2022 - 2028, USD Million
TABLE 281 Asia Pacific Autoimmune Diseases Market by Country, 2018 - 2021, USD Million
TABLE 282 Asia Pacific Autoimmune Diseases Market by Country, 2022 - 2028, USD Million
TABLE 283 Asia Pacific Hepatitis Market by Country, 2018 - 2021, USD Million
TABLE 284 Asia Pacific Hepatitis Market by Country, 2022 - 2028, USD Million
TABLE 285 Asia Pacific Multiple Sclerosis Market by Country, 2018 - 2021, USD Million
TABLE 286 Asia Pacific Multiple Sclerosis Market by Country, 2022 - 2028, USD Million
TABLE 287 Asia Pacific Hemophilia Market by Country, 2018 - 2021, USD Million
TABLE 288 Asia Pacific Hemophilia Market by Country, 2022 - 2028, USD Million
TABLE 289 Asia Pacific Gastrointestinal Disorders Market by Country, 2018 - 2021, USD Million
TABLE 290 Asia Pacific Gastrointestinal Disorders Market by Country, 2022 - 2028, USD Million
TABLE 291 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 292 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 293 Asia Pacific PEGylated Proteins Market by Country, 2018 - 2021, USD Million
TABLE 294 Asia Pacific PEGylated Proteins Market by Country, 2022 - 2028, USD Million
TABLE 295 China PEGylated Proteins Market, 2018 - 2021, USD Million
TABLE 296 China PEGylated Proteins Market, 2022 - 2028, USD Million
TABLE 297 China PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
TABLE 298 China PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
TABLE 299 China PEGylated Proteins Market by Type, 2018 - 2021, USD Million
TABLE 300 China PEGylated Proteins Market by Type, 2022 - 2028, USD Million
TABLE 301 China PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
TABLE 302 China PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
TABLE 303 China PEGylated Proteins Market by Application, 2018 - 2021, USD Million
TABLE 304 China PEGylated Proteins Market by Application, 2022 - 2028, USD Million
TABLE 305 Japan PEGylated Proteins Market, 2018 - 2021, USD Million
TABLE 306 Japan PEGylated Proteins Market, 2022 - 2028, USD Million
TABLE 307 Japan PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
TABLE 308 Japan PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
TABLE 309 Japan PEGylated Proteins Market by Type, 2018 - 2021, USD Million
TABLE 310 Japan PEGylated Proteins Market by Type, 2022 - 2028, USD Million
TABLE 311 Japan PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
TABLE 312 Japan PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
TABLE 313 Japan PEGylated Proteins Market by Application, 2018 - 2021, USD Million
TABLE 314 Japan PEGylated Proteins Market by Application, 2022 - 2028, USD Million
TABLE 315 India PEGylated Proteins Market, 2018 - 2021, USD Million
TABLE 316 India PEGylated Proteins Market, 2022 - 2028, USD Million
TABLE 317 India PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
TABLE 318 India PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
TABLE 319 India PEGylated Proteins Market by Type, 2018 - 2021, USD Million
TABLE 320 India PEGylated Proteins Market by Type, 2022 - 2028, USD Million
TABLE 321 India PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
TABLE 322 India PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
TABLE 323 India PEGylated Proteins Market by Application, 2018 - 2021, USD Million
TABLE 324 India PEGylated Proteins Market by Application, 2022 - 2028, USD Million
TABLE 325 South Korea PEGylated Proteins Market, 2018 - 2021, USD Million
TABLE 326 South Korea PEGylated Proteins Market, 2022 - 2028, USD Million
TABLE 327 South Korea PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
TABLE 328 South Korea PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
TABLE 329 South Korea PEGylated Proteins Market by Type, 2018 - 2021, USD Million
TABLE 330 South Korea PEGylated Proteins Market by Type, 2022 - 2028, USD Million
TABLE 331 South Korea PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
TABLE 332 South Korea PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
TABLE 333 South Korea PEGylated Proteins Market by Application, 2018 - 2021, USD Million
TABLE 334 South Korea PEGylated Proteins Market by Application, 2022 - 2028, USD Million
TABLE 335 Singapore PEGylated Proteins Market, 2018 - 2021, USD Million
TABLE 336 Singapore PEGylated Proteins Market, 2022 - 2028, USD Million
TABLE 337 Singapore PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
TABLE 338 Singapore PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
TABLE 339 Singapore PEGylated Proteins Market by Type, 2018 - 2021, USD Million
TABLE 340 Singapore PEGylated Proteins Market by Type, 2022 - 2028, USD Million
TABLE 341 Singapore PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
TABLE 342 Singapore PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
TABLE 343 Singapore PEGylated Proteins Market by Application, 2018 - 2021, USD Million
TABLE 344 Singapore PEGylated Proteins Market by Application, 2022 - 2028, USD Million
TABLE 345 Malaysia PEGylated Proteins Market, 2018 - 2021, USD Million
TABLE 346 Malaysia PEGylated Proteins Market, 2022 - 2028, USD Million
TABLE 347 Malaysia PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
TABLE 348 Malaysia PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
TABLE 349 Malaysia PEGylated Proteins Market by Type, 2018 - 2021, USD Million
TABLE 350 Malaysia PEGylated Proteins Market by Type, 2022 - 2028, USD Million
TABLE 351 Malaysia PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
TABLE 352 Malaysia PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
TABLE 353 Malaysia PEGylated Proteins Market by Application, 2018 - 2021, USD Million
TABLE 354 Malaysia PEGylated Proteins Market by Application, 2022 - 2028, USD Million
TABLE 355 Rest of Asia Pacific PEGylated Proteins Market, 2018 - 2021, USD Million
TABLE 356 Rest of Asia Pacific PEGylated Proteins Market, 2022 - 2028, USD Million
TABLE 357 Rest of Asia Pacific PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
TABLE 358 Rest of Asia Pacific PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
TABLE 359 Rest of Asia Pacific PEGylated Proteins Market by Type, 2018 - 2021, USD Million
TABLE 360 Rest of Asia Pacific PEGylated Proteins Market by Type, 2022 - 2028, USD Million
TABLE 361 Rest of Asia Pacific PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
TABLE 362 Rest of Asia Pacific PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
TABLE 363 Rest of Asia Pacific PEGylated Proteins Market by Application, 2018 - 2021, USD Million
TABLE 364 Rest of Asia Pacific PEGylated Proteins Market by Application, 2022 - 2028, USD Million
TABLE 365 LAMEA PEGylated Proteins Market, 2018 - 2021, USD Million
TABLE 366 LAMEA PEGylated Proteins Market, 2022 - 2028, USD Million
TABLE 367 LAMEA PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
TABLE 368 LAMEA PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
TABLE 369 LAMEA Consumables Market by Country, 2018 - 2021, USD Million
TABLE 370 LAMEA Consumables Market by Country, 2022 - 2028, USD Million
TABLE 371 LAMEA Services Market by Country, 2018 - 2021, USD Million
TABLE 372 LAMEA Services Market by Country, 2022 - 2028, USD Million
TABLE 373 LAMEA PEGylated Proteins Market by Type, 2018 - 2021, USD Million
TABLE 374 LAMEA PEGylated Proteins Market by Type, 2022 - 2028, USD Million
TABLE 375 LAMEA Colony-stimulating Factor Market by Country, 2018 - 2021, USD Million
TABLE 376 LAMEA Colony-stimulating Factor Market by Country, 2022 - 2028, USD Million
TABLE 377 LAMEA Interferons Market by Country, 2018 - 2021, USD Million
TABLE 378 LAMEA Interferons Market by Country, 2022 - 2028, USD Million
TABLE 379 LAMEA Recombinant Factor VII Market by Country, 2018 - 2021, USD Million
TABLE 380 LAMEA Recombinant Factor VII Market by Country, 2022 - 2028, USD Million
TABLE 381 LAMEA Erythropoietin Market by Country, 2018 - 2021, USD Million
TABLE 382 LAMEA Erythropoietin Market by Country, 2022 - 2028, USD Million
TABLE 383 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 384 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 385 LAMEA PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
TABLE 386 LAMEA PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
TABLE 387 LAMEA Pharmaceutical & Biotechnology Companies Market by Country, 2018 - 2021, USD Million
TABLE 388 LAMEA Pharmaceutical & Biotechnology Companies Market by Country, 2022 - 2028, USD Million
TABLE 389 LAMEA Contract Research Organizations (CROs) Market by Country, 2018 - 2021, USD Million
TABLE 390 LAMEA Contract Research Organizations (CROs) Market by Country, 2022 - 2028, USD Million
TABLE 391 LAMEA Academic & Research Institutes Market by Country, 2018 - 2021, USD Million
TABLE 392 LAMEA Academic & Research Institutes Market by Country, 2022 - 2028, USD Million
TABLE 393 LAMEA PEGylated Proteins Market by Application, 2018 - 2021, USD Million
TABLE 394 LAMEA PEGylated Proteins Market by Application, 2022 - 2028, USD Million
TABLE 395 LAMEA Cancer Market by Country, 2018 - 2021, USD Million
TABLE 396 LAMEA Cancer Market by Country, 2022 - 2028, USD Million
TABLE 397 LAMEA Autoimmune Diseases Market by Country, 2018 - 2021, USD Million
TABLE 398 LAMEA Autoimmune Diseases Market by Country, 2022 - 2028, USD Million
TABLE 399 LAMEA Hepatitis Market by Country, 2018 - 2021, USD Million
TABLE 400 LAMEA Hepatitis Market by Country, 2022 - 2028, USD Million
TABLE 401 LAMEA Multiple Sclerosis Market by Country, 2018 - 2021, USD Million
TABLE 402 LAMEA Multiple Sclerosis Market by Country, 2022 - 2028, USD Million
TABLE 403 LAMEA Hemophilia Market by Country, 2018 - 2021, USD Million
TABLE 404 LAMEA Hemophilia Market by Country, 2022 - 2028, USD Million
TABLE 405 LAMEA Gastrointestinal Disorders Market by Country, 2018 - 2021, USD Million
TABLE 406 LAMEA Gastrointestinal Disorders Market by Country, 2022 - 2028, USD Million
TABLE 407 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 408 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 409 LAMEA PEGylated Proteins Market by Country, 2018 - 2021, USD Million
TABLE 410 LAMEA PEGylated Proteins Market by Country, 2022 - 2028, USD Million
TABLE 411 Brazil PEGylated Proteins Market, 2018 - 2021, USD Million
TABLE 412 Brazil PEGylated Proteins Market, 2022 - 2028, USD Million
TABLE 413 Brazil PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
TABLE 414 Brazil PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
TABLE 415 Brazil PEGylated Proteins Market by Type, 2018 - 2021, USD Million
TABLE 416 Brazil PEGylated Proteins Market by Type, 2022 - 2028, USD Million
TABLE 417 Brazil PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
TABLE 418 Brazil PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
TABLE 419 Brazil PEGylated Proteins Market by Application, 2018 - 2021, USD Million
TABLE 420 Brazil PEGylated Proteins Market by Application, 2022 - 2028, USD Million
TABLE 421 Argentina PEGylated Proteins Market, 2018 - 2021, USD Million
TABLE 422 Argentina PEGylated Proteins Market, 2022 - 2028, USD Million
TABLE 423 Argentina PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
TABLE 424 Argentina PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
TABLE 425 Argentina PEGylated Proteins Market by Type, 2018 - 2021, USD Million
TABLE 426 Argentina PEGylated Proteins Market by Type, 2022 - 2028, USD Million
TABLE 427 Argentina PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
TABLE 428 Argentina PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
TABLE 429 Argentina PEGylated Proteins Market by Application, 2018 - 2021, USD Million
TABLE 430 Argentina PEGylated Proteins Market by Application, 2022 - 2028, USD Million
TABLE 431 UAE PEGylated Proteins Market, 2018 - 2021, USD Million
TABLE 432 UAE PEGylated Proteins Market, 2022 - 2028, USD Million
TABLE 433 UAE PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
TABLE 434 UAE PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
TABLE 435 UAE PEGylated Proteins Market by Type, 2018 - 2021, USD Million
TABLE 436 UAE PEGylated Proteins Market by Type, 2022 - 2028, USD Million
TABLE 437 UAE PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
TABLE 438 UAE PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
TABLE 439 UAE PEGylated Proteins Market by Application, 2018 - 2021, USD Million
TABLE 440 UAE PEGylated Proteins Market by Application, 2022 - 2028, USD Million
TABLE 441 Saudi Arabia PEGylated Proteins Market, 2018 - 2021, USD Million
TABLE 442 Saudi Arabia PEGylated Proteins Market, 2022 - 2028, USD Million
TABLE 443 Saudi Arabia PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
TABLE 444 Saudi Arabia PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
TABLE 445 Saudi Arabia PEGylated Proteins Market by Type, 2018 - 2021, USD Million
TABLE 446 Saudi Arabia PEGylated Proteins Market by Type, 2022 - 2028, USD Million
TABLE 447 Saudi Arabia PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
TABLE 448 Saudi Arabia PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
TABLE 449 Saudi Arabia PEGylated Proteins Market by Application, 2018 - 2021, USD Million
TABLE 450 Saudi Arabia PEGylated Proteins Market by Application, 2022 - 2028, USD Million
TABLE 451 South Africa PEGylated Proteins Market, 2018 - 2021, USD Million
TABLE 452 South Africa PEGylated Proteins Market, 2022 - 2028, USD Million
TABLE 453 South Africa PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
TABLE 454 South Africa PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
TABLE 455 South Africa PEGylated Proteins Market by Type, 2018 - 2021, USD Million
TABLE 456 South Africa PEGylated Proteins Market by Type, 2022 - 2028, USD Million
TABLE 457 South Africa PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
TABLE 458 South Africa PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
TABLE 459 South Africa PEGylated Proteins Market by Application, 2018 - 2021, USD Million
TABLE 460 South Africa PEGylated Proteins Market by Application, 2022 - 2028, USD Million
TABLE 461 Nigeria PEGylated Proteins Market, 2018 - 2021, USD Million
TABLE 462 Nigeria PEGylated Proteins Market, 2022 - 2028, USD Million
TABLE 463 Nigeria PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
TABLE 464 Nigeria PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
TABLE 465 Nigeria PEGylated Proteins Market by Type, 2018 - 2021, USD Million
TABLE 466 Nigeria PEGylated Proteins Market by Type, 2022 - 2028, USD Million
TABLE 467 Nigeria PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
TABLE 468 Nigeria PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
TABLE 469 Nigeria PEGylated Proteins Market by Application, 2018 - 2021, USD Million
TABLE 470 Nigeria PEGylated Proteins Market by Application, 2022 - 2028, USD Million
TABLE 471 Rest of LAMEA PEGylated Proteins Market, 2018 - 2021, USD Million
TABLE 472 Rest of LAMEA PEGylated Proteins Market, 2022 - 2028, USD Million
TABLE 473 Rest of LAMEA PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
TABLE 474 Rest of LAMEA PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
TABLE 475 Rest of LAMEA PEGylated Proteins Market by Type, 2018 - 2021, USD Million
TABLE 476 Rest of LAMEA PEGylated Proteins Market by Type, 2022 - 2028, USD Million
TABLE 477 Rest of LAMEA PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
TABLE 478 Rest of LAMEA PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
TABLE 479 Rest of LAMEA PEGylated Proteins Market by Application, 2018 - 2021, USD Million
TABLE 480 Rest of LAMEA PEGylated Proteins Market by Application, 2022 - 2028, USD Million
TABLE 481 Key Information – Thermo Fisher Scientific, Inc.
TABLE 482 Key Information – Merck Millipore
TABLE 483 Key Information – nof corporation
TABLE 484 Key Information – Beijing Jiankai Technology Co., Ltd.
TABLE 485 Key Information – Creative PEGworks
TABLE 486 Key Information – Celares gmbh
TABLE 487 Key Information –Quanta biodesign ltd.
TABLE 488 Key Information – biomatrik, inc.
TABLE 489 Key Information – Iris biotech gmbh
TABLE 490 Key Information – laysan bio, inc.

List of Figures
FIG 1 Methodology for the research
FIG 2 Global PEGylated Proteins Market Share by Product & Services, 2021
FIG 3 Global PEGylated Proteins Market Share by Product & Services, 2028
FIG 4 Global PEGylated Proteins Market by Product & Services, 2018 - 2028, USD Million
FIG 5 Global PEGylated Proteins Market Share by Type, 2021
FIG 6 Global PEGylated Proteins Market Share by Type, 2028
FIG 7 Global PEGylated Proteins Market by Type, 2018 - 2028, USD Million
FIG 8 Global PEGylated Proteins Market Share by End-user, 2021
FIG 9 Global PEGylated Proteins Market Share by End-user, 2028
FIG 10 Global PEGylated Proteins Market by End-user, 2018 - 2028, USD Million
FIG 11 Global PEGylated Proteins Market Share by Application, 2021
FIG 12 Global PEGylated Proteins Market Share by Application, 2028
FIG 13 Global PEGylated Proteins Market by Application, 2018 - 2028, USD Million
FIG 14 Global PEGylated Proteins Market Share by Region, 2021
FIG 15 Global PEGylated Proteins Market Share by Region, 2028
FIG 16 Global PEGylated Proteins Market by Region, 2018 - 2028, USD Million
FIG 17 Recent strategies and developments: Thermo Fisher Scientific, Inc.

Purchase Full Report of
PEGylated Proteins Market

Buy Now

Avail up to 60% discount on subscription plans on

SUBSCRIPTION MODEL

© 2024 KBV Research. All Rights Reserved